Urinary Bladder DiseasesUrinary BladderCyclophosphamideUrinary Bladder NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsDoxorubicinVincristinePhosphoramide MustardsAntineoplastic Agents, AlkylatingPrednisoneUrinary Bladder, OveractiveDrug Administration ScheduleCystitisToxicity TestsMethotrexateImmunosuppressive AgentsTreatment OutcomeUrinary Bladder, NeurogenicCombined Modality TherapyEtoposidePulse Therapy, DrugEpirubicinCarcinoma, Transitional CellDose-Response Relationship, DrugUrinary Bladder Neck ObstructionUrinary Bladder CalculiFluorouracilThiotepaBusulfanBreast NeoplasmsRemission InductionDisease-Free SurvivalLeukopeniaUrotheliumPrednisoloneAntineoplastic AgentsAntibodies, Monoclonal, Murine-DerivedSurvival AnalysisLymphoma, Non-HodgkinTime FactorsGranulocyte Colony-Stimulating FactorCisplatinBone Marrow TransplantationVidarabineSurvival RateTransplantation, AutologousToxicity Tests, AcuteChemotherapy, AdjuvantUrinationBladder ExstrophyHematopoietic Stem Cell TransplantationDrug Therapy, CombinationMethylprednisoloneCystoscopyWhole-Body IrradiationCarmustineAdministration, IntravesicalNeutropeniaMelphalanAdministration, MetronomicFollow-Up StudiesNeoplasm StagingIfosfamideTransplantation ConditioningInfusions, IntravenousMesnaPaclitaxelAcroleinImmunosuppressionAzathioprineRecurrenceWegener GranulomatosisAdministration, OralCystectomyMitoxantronePrognosisLupus NephritisBleomycinCarboplatinNeoplasmsChlorambucilDrug EvaluationTransplantation, HomologousAlkylating AgentsLeukocyte CountCytarabineAntibodies, MonoclonalProcarbazineThrombocytopeniaNeoplasm Recurrence, LocalUrodynamicsTaxoidsHematopoietic Stem Cell MobilizationProspective StudiesDexamethasoneRetrospective StudiesBiotransformationBone MarrowInjections, IntravenousVomiting